MAZEMaze Therapeutics

Median target
$56
calls from the last 12 months
Implied return
+138.9%
median target vs. price
Coverage
10 analysts · 11 calls
updated in the last 12 months
Consensus
10/0/0+10 net
Buy / Hold / Sell

Which analysts are behind MAZE's consensus?

See every current rating, price target and the analysts' track records for Maze Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 10 analysts with calls on MAZE updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

MAZE elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-04InsidersBernstein HaroldPresident, R&D & CMOInsider sale9.7K sh @ $26.22 · planned trade$255K
2026-09-03InsidersColoma Jason VChief Executive OfficerInsider sale11.3K sh @ $26.01$293K
2026-09-03InsidersBernstein HaroldPresident, R&D & CMOInsider sale5.1K sh @ $26.01$133K
2026-09-03InsidersDandekar AtulCSBOInsider sale3.2K sh @ $26.01$83K
2026-09-03InsidersCourtney PhillipsGC and Corp. SecretaryInsider sale2.0K sh @ $26.01$52K
2026-09-03InsidersColoma Jason VChief Executive OfficerInsider sale129 sh @ $25.77$3K
2026-09-03InsidersBernstein HaroldPresident, R&D & CMOInsider sale59 sh @ $25.78$2K
2026-09-03InsidersDandekar AtulCSBOInsider sale36 sh @ $25.81$929
2026-09-03InsidersCourtney PhillipsGC and Corp. SecretaryInsider sale22 sh @ $25.78$567
2026-09-02InsidersColoma Jason VChief Executive OfficerInsider sale9.9K sh @ $26.38$260K

More: insider activity · executive branch · trending